Online Public Engagement

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

 

Online public engagement is in line with the government's aspiration to support the principles of transparency and equality for the implementation of a law.

Therefore, this page is available for public consultation and will present new proposals or amendments to the draft law (including laws, policies, regulations, etc.). The draft will appear on this page for a period of 14 working days.

The public is encouraged to provide comments and views on the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia during this period.

 

 

Cadangan Pindaan Baru Di Bawah Peraturan Kawalan Dadah Dan Kosmetik 

Tempoh untuk maklumbalas : 22/02/2019 - 23/03/2019

 

Guideline 

 

Bil Tajuk / Klausa / Dokumen Muat Turun
1. Guideline On Natural Products With Therapeutic Claim Download

 

Slides 

Bil Dokumen Muat Turun
1. Slaid Guideline On Natural Products With Therapeutic Claim Download
2.  Public Consultation On Implementation Of Manufacturing License For Cosmetic Manufacturer Download

 

 

Maklumbalas Cadangan Pindaan Baru Di Bawah Peraturan Kawalan Dadah Dan Kosmetik

Bil Dokumen Muat Turun
1. Borang Maklumbalas Seranta Awam Cadangan Pindaan Baru Di Bawah Peraturan Kawalan Dadah Dan Kosmetik 1984 Download

 Borang ini boleh dikembalikan semula kepada Bahagian Regulatori Farmasi Negara (NPRA) menerusi alamat emel (This email address is being protected from spambots. You need JavaScript enabled to view it.), untuk perhatian Pn. Kamilah selewat-lewatnya 22 Mac 2019.

 

Comments (7)

  1. Christine Siew

Hi NPRA, for the "Borang Maklumbalas Seranta Awam Cadangan Pindaan Baru Di Bawah Peraturan Kawalan Dadah Dan Kosmetik 1984", when click "download", it is the slides "GUIDELINE ON NATURAL PRODUCTS WITH THERAPEUTIC CLAIM" but not the form. May I...

Hi NPRA, for the "Borang Maklumbalas Seranta Awam Cadangan Pindaan Baru Di Bawah Peraturan Kawalan Dadah Dan Kosmetik 1984", when click "download", it is the slides "GUIDELINE ON NATURAL PRODUCTS WITH THERAPEUTIC CLAIM" but not the form. May I kindly request for the form please? Many thanks.

Read More
 
  1. Jauze    Christine Siew

Dear Christine Siew,

We have fixed the documents link. Thank you for notify us

 
  1. Sara syahira binti ruzman

Hi... adakah produk phytax dari eskayvie selamat untuk diamalkan ? Pengasas adlah dari dr syid ayob. Terima kasih

 
  1. nur.fariza

Hi saya nak tanya adakah produk Maeyra Milk Booster dan Moeder Milk Booster selamat digunakan???

 
  1. Alexius pius

Cardio trust. Adakah produk ni berdaftar

 
  1. Maisarah

Hi, kalau nak cek untuk makanan (supplement) yang dikelaskan sebagai makanan misalnya, lulus KKM tapi tak perlukan NOT dan MAL disebabkan ia dikelaskan sebagai makanan, perlu check dimana? Saya tak jumpa link berkaitan.

 
  1. Jonathan Chew

Hi, i will like to ask, for Complementary Medical Practitioners that are registered with T&CM division MOH, could there be a clause for them to use products that are therapeutic in dosage? because the nature of their treatment required dosages...

Hi, i will like to ask, for Complementary Medical Practitioners that are registered with T&CM division MOH, could there be a clause for them to use products that are therapeutic in dosage? because the nature of their treatment required dosages above RDA for any therapeutic effect.

If products of RDA levels are use, consumers or patients might be burdened with the many tables to swallow and also financially heavy.

Please advice if such options are available for discussion.

Read More
 
There are no comments posted here yet

Leave your comments

Posting comment as a guest.
0 Characters
Attachments (0 / 3)
Share Your Location

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Friday 19 April 2019, 08:48:21.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language